Clinical Trials Browser

Active not recruiting × Has results × Interleukin-2 × Clear all

NCT03474497 2026-01-29

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Phase 1/2 Active not recruiting

18 enrolled 13 charts

DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT01416831 2025-03-17

SBRT/IL-2

Phase 2 Active not recruiting

44 enrolled 12 charts

Melanoma